New research links genetic defects in carbohydrate digestion to irritable bowel syndrome

“People with IBS often connect their symptoms to certain foods, particularly fermentable carbohydrates. We tested the hypothesis that genetic changes in the breakdown of disaccharides – small carbohydrates from sugars and starches – may be associated with increased risk of IBS” says corresponding author Mauro D’Amato from Karolinska Institutet.

Posted in Featured, News | Kommentarer inaktiverade för New research links genetic defects in carbohydrate digestion to irritable bowel syndrome

Positive 2-year results with MD1003 in progressive MS

MedDay Reports Full Data from Pivotal Phase IIb/III MS-SPI / MS-ON Studies with MD1003 in Multiple Sclerosis at AAN

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Positive 2-year results with MD1003 in progressive MS

GS-101 (aganirsen) in the Nordic countries

Gene Signal and Medical Need enter into collaboration for GS-101 (aganirsen) in the Nordic countries Medical Need announced today that it has entered into an exclusive supply and distribution agreement with Swiss company Gene Signal, relating to their product GS-101…

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för GS-101 (aganirsen) in the Nordic countries

Medical Need and Laboratoires CTRS in Nordic collaboration

Medical Need and Laboratoires CTRS enter into a collaboration for the Nordic countries Medical Need announced today that it has entered into an exclusive supply and distribution agreement with the French company Laboratoires CTRS, regarding marketing and sale of CTRS…

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Medical Need and Laboratoires CTRS in Nordic collaboration

Medical Needs partner Atlantic Healthcare announces start of pivotal PhIII trial with alicaforsen in pouchitis

Study of fast-tracked and orphan designated alicaforsen is the largest ever in pouchitis, and aims to confirm efficacy in antibiotic refractory patients Read full pressrelease here    

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Medical Needs partner Atlantic Healthcare announces start of pivotal PhIII trial with alicaforsen in pouchitis

Additional results for MD1003 (Cerenday)

Press release: MedDay Reports Additional Positive Data of its Pivotal Phase III Study With MD1003 in Patients with Progressive Multiple Sclerosis   Improvement of Clinical Global Impression of change evaluated by the physician (CGI) and by the patient (SGI) at…

Posted in Medical Need, Medical Need, News | Kommentarer inaktiverade för Additional results for MD1003 (Cerenday)

Medical Need´s partner company, announces positive data from study with MD 1003 for treatment of progressive MS

Paris, France, April 24 2015 – MedDay, a biotechnology company focused on the treatment of nervous system disorders, today announced positive results from the pivotal Phase III clinical trial, MS-SPI, which showed evidence of the efficacy and safety of MD1003,…

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Medical Need´s partner company, announces positive data from study with MD 1003 for treatment of progressive MS

Multi-drug resistant tuberculosis (MDR-TB)

“Multi-drug resistant tuberculosis is a major threat to public health globally, and is a significant and growing problem. GranuPAS® is one of the important pharmaceuticals used to cure this severe disease, and to prevent further development of resistance among tuberculosis bacteria and spread of tuberculosis in the society”, said Kennet Rooth, COO of Medical Need

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Multi-drug resistant tuberculosis (MDR-TB)

Chronic remitting pouchitis

“We are very happy to initiate this partnership with Atlantic Pharmaceuticals” said Kennet Rooth, COO of Medical Need, and continued, “IBD can cause significant suffering for patients with moderate-severe disease, for which there are limited treatment options. The clinical studies conducted to date with Alicaforsen enema show that it has the potential to be a safe and effective option for alleviating the underlying inflammation and symptoms in specific situations, including pouchitis, where there are currently no approved treatments.”

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Chronic remitting pouchitis

Multi-drug resistant tuberculosis (MDR-TB)

Medical Need gains rights to treatment for multi drug resistant tubeculosis (MDR-TB)
Multi-drug resistant tuberculosis is a major threat to public health globally, and is a growing problem also in the Nordic countries.

Posted in Featured, Medical Need, News | Kommentarer inaktiverade för Multi-drug resistant tuberculosis (MDR-TB)

Produced by 6ft5 & Krokedil.

Produced by 6ft5 & Krokedil.